Real-world Safety of Vedolizumab and Anti-TNF Therapies in Biologic-Naïve Ulcerative Colitis and Crohn's Disease Patients: Results from the EVOLVE study

Andres Yarur  1     Gerassimos J. Mantzaris  2     Uri Kopylov  3     Marielle Bassel  4     Neil Brett  4     Trevor Lissoos  5     claudia lopez  5     Athanasios Natsios  6     Christina Kifnidi  7     Sumit Saha     Dirk Demuth     Haridarshan Patel     Brian Bressler    
1 Medical College of Wisconsin,Milwaukee,United States
2 Evangelismos Hospital,Athens,Greece
3 Chaim Sheba Medical Center,Ramat Gan,Israel
4 Evidera,Montreal,Canada
5 Takeda Pharmaceuticals USA Inc,Deerfield,United States
6 Takeda Hellas S.A.,Athens,Greece
7 T

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing